Home

Colgate Announces 4th Quarter and Full Year 2024 Results

Colgate-Palmolive Company (NYSE:CL):

Full Year

  • Delivered over $20 billion in Net sales for the first time
  • Net sales increased 3.3%; Organic sales* increased 7.4%, including a 0.5% negative impact from lower private label pet volume
  • GAAP EPS increased 27% to $3.51; Base Business EPS* increased 11% to $3.60
  • Net cash provided by operations was $4,107 for the full year, up 10% versus 2023
  • Returned $3.4 billion in cash to shareholders through dividends and share repurchases

Full Year Total Company Results (GAAP)

($ in millions except per share amounts)

2024

2023

Change

Net Sales

$20,101

$19,457

+3.3% 

EPS (diluted)

$3.51

$2.77

+27% 

 

 

 

 

Full Year Total Company Results (Base Business - Non-GAAP)*

($ in millions except per share amounts)

2024

2023

Change

Organic Sales Growth

+7.4% 

Base Business EPS (diluted)

$3.60

$3.23

+11% 

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 7 - Geographic Sales Analysis Percentage Changes” and “Table 9 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Fourth Quarter

  • Net sales decreased 0.1%; Organic sales* increased 4.3%, including a 0.5% negative impact from lower private label pet volume
  • GAAP EPS increased 3% to $0.90; Base Business EPS* increased 5% to $0.91
  • GAAP Gross profit margin and Base Business Gross profit margin* both increased 70 basis points to 60.3%
  • Colgate’s leadership in toothpaste continued with its global market share at 41.4% year to date
  • Colgate’s leadership in manual toothbrushes continued with its global market share at 32.2% year to date

Fourth Quarter Total Company Results (GAAP)

($ in millions except per share amounts)

2024

2023

Change

Net Sales

$4,944

$4,950

-0.1%

EPS (diluted)

$0.90

$0.87

+3%

 

 

 

 

Fourth Quarter Total Company Results (Base Business - Non-GAAP)*

($ in millions except per share amounts)

2024

2023

Change

Organic Sales Growth

+4.3%

Base Business EPS (diluted)

$0.91

$0.87

+5%

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Colgate-Palmolive Company (NYSE:CL) today reported results for fourth quarter and full year 2024. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business fourth quarter and full year results, “We are pleased to have delivered another quarter and full year of strong organic sales growth along with increases in gross profit, gross profit margin, net income, earnings per share and cash flow. Our goals for 2024 were to deliver peer leading growth while funding investment for future growth and building flexibility into our P&L to counter macro headwinds. We delivered on those goals, leaving us well positioned to deliver against our guidance in 2025.

“For the full year, we grew net sales 3.3% and organic sales 7.4%, with organic sales growth in every division and in all four of our categories. This was our sixth consecutive year with organic sales growth at or above our 3% to 5% targeted range. The combination of strong sales growth and operating leverage drove strong bottom-line performance as well, with net income and earnings per share both increasing double digits versus 2023.

“Our strong margin performance allowed us to continue to invest to drive brand health and support innovation with a 15% increase in advertising spending in 2024, following a 19% increase in 2023. We have built flexibility into our income statement so we can continue to invest in scaling our capabilities in key areas like digital and data and analytics across the organization to accelerate change and build competitive advantages, while delivering bottom-line growth.

“Reaching $20 billion in net sales for the year is an exciting milestone and I’d like to thank all Colgate people globally for their hard work and dedication to achieving our goals together. The quality of our results this year and our strong growth momentum add to our confidence that we are well positioned to deliver consistent, compounded earnings per share growth in 2025 and beyond.”

Full Year 2025 Guidance

Based on current spot rates:

  • The Company expects net sales to be roughly flat, including a mid-single-digit negative impact from foreign exchange.
  • The Company expects organic sales growth to be within its long-term targeted range of 3% to 5%, including the impact of the planned exit from private label pet nutrition over the course of 2025.
  • On a GAAP basis, the Company expects gross profit margin expansion with advertising investment flat to up slightly on both a dollar basis and as a percent to sales and mid-single-digit earnings-per-share growth.
  • On a non-GAAP (Base Business) basis, the Company expects gross profit margin expansion with advertising investment flat to up slightly on both a dollar basis and as a percent to sales and low to mid-single-digit earnings-per-share growth.

Divisional Performance

The following are comments about divisional performance for fourth quarter 2024 versus the year ago period. See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.

Fourth Quarter Sales Growth By Division

(% change 4Q 2024 vs. 4Q 2023)

 

 

 

% of Total

Company

Sales

Net

Sales

Organic

Sales*

 

Volume

Pricing

FX

North America(1)

21.0%

-1.0%

-0.7%

+1.9%

-2.7%

-0.3%

Latin America

22.4%

-7.2%

+9.2%

+0.9%

+8.3%

-16.4%

Europe(1)

13.5%

+4.9%

+4.5%

+1.7%

+2.7%

+0.4%

Asia Pacific

14.6%

+3.7%

+3.8%

+5.8%

-2.0%

—%

Africa/Eurasia

5.4%

+2.8%

+9.4%

+11.5%

-2.1%

-6.6%

Hill's

23.1%

+2.3%

+2.9%

+0.8%

+2.0%

-0.5%

 

 

 

 

 

 

 

Total Company

100.0%

-0.1%

+4.3%

+2.5%

+1.8%

-4.4%

Note: Table may not sum due to rounding.

 

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024. The results of the skin health business previously reported within the Europe reportable operating segment are reported with the other skin health businesses in the North America reportable operating segment. Recast historical geographic segment information can be found on the Company's website.

 

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Fourth Quarter Operating Profit By Division

($ in millions)

 

 

4Q 2024

% Change vs

4Q 2023

% to Net Sales

Change in basis

points vs 4Q 2023

% to Net Sales

North America(1)

$206

-11%

19.9%

-220

Latin America

$339

-8%

30.6%

-10

Europe(1)

$155

3%

23.3%

-40

Asia Pacific

$211

4%

29.1%

+10

Africa/Eurasia

$58

-1%

21.5%

-80

Hill's

$275

19%

24.1%

+340

 

 

 

 

 

Total Company, As Reported

$1,064

-1%

21.5%

-20

Total Company, Base Business*

$1,071

—%

21.7%

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

 

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Prepared Materials and Webcast Information

At approximately 7:00 a.m. ET today, Colgate will post its prepared materials (in PDF format) regarding fourth quarter and full year 2024 results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.

At 8:30 a.m. ET today, Colgate will host a conference call regarding fourth quarter and full year 2024 results. To access this call as a webcast, please go to Colgate’s website at www.colgatepalmolive.com.

About Colgate-Palmolive

Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. The Company is recognized for its leadership and innovation in promoting sustainability and community wellbeing, including its achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children’s oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.8 billion children and their families since 1991. For more information about Colgate’s global business and how the Company is building a future to smile about, visit www.colgatepalmolive.com. CL-E

The Company's annual meeting of stockholders is currently scheduled for Friday, May 9, 2025.

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange, the impact of any additional tariffs, the impact of the war in Ukraine, the conflict in the Middle East and tensions between China and Taiwan, cost-reduction plans, tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at www.colgatepalmolive.com.

Non-GAAP Financial Measures

The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:

  • Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to an ERISA litigation matter, a foreign tax matter, the 2022 Global Productivity Initiative and product recall costs.
  • Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
  • Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and twelve months ended December 31, 2024 versus 2023 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations” for the three and twelve months ended December 31, 2024 and 2023 included with this release for a reconciliation of these financial measures to the related GAAP measures.

The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the twelve months ended December 31, 2024 and 2023 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

(See attached tables for fourth quarter and full year results.)

 

 

 

 

Table 1

Colgate-Palmolive Company

 

Condensed Consolidated Statements of Income

 

For the Three Months Ended December 31, 2024 and 2023

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

 

 

 

2024

 

 

 

2023

 

 

 

 

 

 

Net sales

 

$

4,944

 

 

$

4,950

 

 

 

 

 

 

Cost of sales

 

 

1,962

 

 

 

2,000

 

 

 

 

 

 

Gross profit

 

 

2,982

 

 

 

2,950

 

 

 

 

 

 

Gross profit margin

 

 

60.3

%

 

 

59.6

%

 

 

 

 

 

Selling, general and administrative expenses

 

 

1,895

 

 

 

1,803

 

 

 

 

 

 

Other (income) expense, net

 

 

23

 

 

 

75

 

 

 

 

 

 

Operating profit

 

 

1,064

 

 

 

1,072

 

 

 

 

 

 

Operating profit margin

 

 

21.5

%

 

 

21.7

%

 

 

 

 

 

Non-service related postretirement costs

 

 

20

 

 

 

22

 

 

 

 

 

 

Interest expense

 

 

66

 

 

 

74

 

 

 

 

 

 

Interest income

 

 

16

 

 

 

12

 

 

 

 

 

 

Income before income taxes

 

 

994

 

 

 

988

 

 

 

 

 

 

Provision for income taxes

 

 

215

 

 

 

228

 

 

 

 

 

 

Effective tax rate

 

 

21.6

%

 

 

23.1

%

 

 

 

 

 

Net income including noncontrolling interests

 

 

779

 

 

 

760

 

 

 

 

 

 

Less: Net income attributable to noncontrolling interests

 

 

40

 

 

 

42

 

 

 

 

 

 

Net income attributable to Colgate-Palmolive Company

 

$

739

 

 

$

718

 

 

 

 

 

 

Earnings per common share

 

 

 

 

Basic

 

$

0.91

 

 

$

0.87

 

Diluted

 

$

0.90

 

 

$

0.87

 

 

 

 

 

 

Supplemental Income Statement Information

 

 

 

 

Average common shares outstanding

 

 

 

 

Basic

 

 

816.0

 

 

 

823.4

 

Diluted

 

 

819.7

 

 

 

825.1

 

 

 

 

 

 

Advertising

 

$

648

 

 

$

593

 

 

 

 

 

 

 

 

 

 

Table 2

Colgate-Palmolive Company

 

Condensed Consolidated Statements of Income

 

For the Twelve Months Ended December 31, 2024 and 2023

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

 

 

 

2024

 

 

 

2023

 

 

 

 

 

 

Net sales

 

$

20,101

 

 

$

19,457

 

 

 

 

 

 

Cost of sales

 

 

7,940

 

 

 

8,131

 

 

 

 

 

 

Gross profit

 

 

12,161

 

 

 

11,326

 

 

 

 

 

 

Gross profit margin

 

 

60.5

%

 

 

58.2

%

 

 

 

 

 

Selling, general and administrative expenses

 

 

7,729

 

 

 

7,151

 

 

 

 

 

 

Other (income) expense, net

 

 

164

 

 

 

191

 

 

 

 

 

 

Operating profit

 

 

4,268

 

 

 

3,984

 

 

 

 

 

 

Operating profit margin

 

 

21.2

%

 

 

20.5

%

 

 

 

 

 

Non-service related postretirement costs

 

 

87

 

 

 

360

 

 

 

 

 

 

Interest expense

 

 

292

 

 

 

287

 

 

 

 

 

 

Interest income

 

 

67

 

 

 

55

 

 

 

 

 

 

Income before income taxes

 

 

3,956

 

 

 

3,392

 

 

 

 

 

 

Provision for income taxes

 

 

907

 

 

 

937

 

 

 

 

 

 

Effective tax rate

 

 

22.9

%

 

 

27.6

%

 

 

 

 

 

Net income including noncontrolling interests

 

 

3,049

 

 

 

2,455

 

 

 

 

 

 

Less: Net income attributable to noncontrolling interests

 

 

160

 

 

 

155

 

 

 

 

 

 

Net income attributable to Colgate-Palmolive Company

 

$

2,889

 

 

$

2,300

 

 

 

 

 

 

Earnings per common share

 

 

 

 

Basic(1)

 

$

3.53

 

 

$

2.78

 

Diluted(1)

 

$

3.51

 

 

$

2.77

 

 

 

 

 

 

Supplemental Income Statement Information

 

 

 

 

Average common shares outstanding

 

 

 

 

Basic

 

 

819.1

 

 

 

827.4

 

Diluted

 

 

823.2

 

 

 

829.2

 

 

 

 

 

 

Advertising

 

$

2,720

 

 

$

2,371

 

Note:

(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period.

 

 

 

Table 3

Colgate-Palmolive Company

 

Condensed Consolidated Balance Sheets

 

As of December 31, 2024 and December 31, 2023

 

(Dollars in Millions) (Unaudited)

 

 

 

 

 

 

 

 

2024

 

 

 

2023

 

Cash and cash equivalents

 

$

1,096

 

 

$

966

 

Receivables, net

 

 

1,521

 

 

 

1,586

 

Inventories

 

 

1,987

 

 

 

1,934

 

Other current assets

 

 

713

 

 

 

793

 

Property, plant and equipment, net

 

 

4,422

 

 

 

4,582

 

Goodwill

 

 

3,272

 

 

 

3,410

 

Other intangible assets, net

 

 

1,756

 

 

 

1,887

 

Other assets

 

 

1,279

 

 

 

1,235

 

Total assets

 

$

16,046

 

 

$

16,393

 

 

 

 

 

 

Total debt

 

 

7,949

 

 

 

8,549

 

Other current liabilities

 

 

5,099

 

 

 

4,411

 

Other non-current liabilities

 

 

2,454

 

 

 

2,476

 

Total liabilities

 

 

15,502

 

 

 

15,436

 

Total Colgate-Palmolive Company shareholders’ equity

 

 

212

 

 

 

609

 

Noncontrolling interests

 

 

332

 

 

 

348

 

Total liabilities and equity

 

$

16,046

 

 

$

16,393

 

 

 

 

 

 

Supplemental Balance Sheet Information

 

 

 

 

Debt less cash, cash equivalents and marketable securities(1)

 

$

6,693

 

 

$

7,404

 

Working capital % of sales

 

 

(5.2

)%

 

 

(1.4

)%

Note:

(1) Marketable securities of $160 and $179 as of December 31, 2024 and 2023, respectively, are included in Other current assets.

 

 

 

 

Table 4

Colgate-Palmolive Company

 

Condensed Consolidated Statements of Cash Flows

 

For the Twelve Months Ended December 31, 2024 and 2023

 

(Dollars in Millions) (Unaudited)

 

 

 

 

 

 

 

 

2024

 

 

 

2023

 

Operating Activities

 

 

 

 

Net income including noncontrolling interests

 

$

3,049

 

 

$

2,455

 

Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations:

 

 

 

 

Depreciation and amortization

 

 

605

 

 

 

567

 

ERISA litigation matter

 

 

 

 

 

267

 

Restructuring and termination benefits, net of cash

 

 

51

 

 

 

(23

)

Stock-based compensation expense

 

 

135

 

 

 

122

 

Deferred income taxes

 

 

(77

)

 

 

(98

)

Cash effects of changes in:

 

 

 

 

Receivables

 

 

(56

)

 

 

(37

)

Inventories

 

 

(100

)

 

 

194

 

Accounts payable and other accruals

 

 

516

 

 

 

309

 

Other non-current assets and liabilities

 

 

(16

)

 

 

(11

)

Net cash provided by operations

 

 

4,107

 

 

 

3,745

 

 

 

 

 

 

Investing Activities

 

 

 

 

Capital expenditures

 

 

(561

)

 

 

(705

)

Purchases of marketable securities and investments

 

 

(574

)

 

 

(506

)

Proceeds from sale of marketable securities and investments

 

 

564

 

 

 

502

 

Other investing activities

 

 

37

 

 

 

(33

)

Net cash used in investing activities

 

 

(534

)

 

 

(742

)

 

 

 

 

 

Financing Activities

 

 

 

 

Short-term borrowing (repayment) less than 90 days, net

 

 

93

 

 

 

(906

)

Principal payments on debt

 

 

(503

)

 

 

(903

)

Proceeds from issuance of debt

 

 

2

 

 

 

1,495

 

Dividends paid

 

 

(1,789

)

 

 

(1,749

)

Purchases of treasury shares

 

 

(1,739

)

 

 

(1,128

)

Proceeds from exercise of stock options

 

 

638

 

 

 

380

 

Other financing activities

 

 

(91

)

 

 

18

 

Net cash used in financing activities

 

 

(3,389

)

 

 

(2,793

)

 

 

 

 

 

Effect of exchange rate changes on Cash and cash equivalents

 

 

(54

)

 

 

(19

)

Net increase (decrease) in Cash and cash equivalents

 

 

130

 

 

 

191

 

Cash and cash equivalents at beginning of the period

 

 

966

 

 

 

775

 

Cash and cash equivalents at end of the period

 

$

1,096

 

 

$

966

 

Supplemental Cash Flow Information

 

 

 

 

Free cash flow before dividends (Net cash provided by operations less Capital expenditures)

 

 

 

 

Net cash provided by operations

 

 

4,107

 

 

 

3,745

 

Less: Capital expenditures

 

 

(561

)

 

 

(705

)

Free cash flow before dividends

 

$

3,546

 

 

$

3,040

 

 

 

 

 

 

Income taxes paid

 

$

933

 

 

$

937

 

Interest paid

 

$

302

 

 

$

280

 

 

 

 

 

 

 

 

 

 

Table 5

Colgate-Palmolive Company

 

 

 

 

 

Segment Information

 

 

 

 

 

For the Three and Twelve Months Ended December 31, 2024 and 2023

 

 

 

 

 

(Dollars in Millions) (Unaudited)

 

 

 

 

 

 

 

 

 

Three Months Ended December 31,

 

Twelve Months Ended December 31,

 

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

Net Sales

 

 

 

 

 

 

 

 

Oral, Personal and Home Care

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America(1)

 

$

1,036

 

 

$

1,047

 

 

$

4,113

 

 

$

4,091

 

Latin America

 

 

1,106

 

 

 

1,192

 

 

 

4,782

 

 

 

4,640

 

Europe(1)

 

 

668

 

 

 

637

 

 

 

2,770

 

 

 

2,571

 

Asia Pacific

 

 

724

 

 

 

698

 

 

 

2,858

 

 

 

2,782

 

Africa/Eurasia

 

 

269

 

 

 

262

 

 

 

1,095

 

 

 

1,083

 

 

 

 

 

 

 

 

 

 

Total Oral, Personal and Home Care

 

 

3,804

 

 

 

3,836

 

 

 

15,618

 

 

 

15,167

 

 

 

 

 

 

 

 

 

 

Pet Nutrition

 

 

1,140

 

 

 

1,114

 

 

 

4,483

 

 

 

4,290

 

 

 

 

 

 

 

 

 

 

Total Net Sales

 

$

4,944

 

 

$

4,950

 

 

$

20,101

 

 

$

19,457

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31,

 

Twelve Months Ended December 31,

 

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

Operating Profit

 

 

 

 

 

 

 

 

Oral, Personal and Home Care

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America(1)

 

$

206

 

 

$

231

 

 

$

839

 

 

$

871

 

Latin America

 

 

339

 

 

 

366

 

 

 

1,526

 

 

 

1,417

 

Europe(1)

 

 

155

 

 

 

151

 

 

 

658

 

 

 

573

 

Asia Pacific

 

 

211

 

 

 

203

 

 

 

812

 

 

 

767

 

Africa/Eurasia

 

 

58

 

 

 

59

 

 

 

253

 

 

 

254

 

 

 

 

 

 

 

 

 

 

Total Oral, Personal and Home Care

 

 

969

 

 

 

1,010

 

 

 

4,088

 

 

 

3,882

 

 

 

 

 

 

 

 

 

 

Pet Nutrition

 

 

275

 

 

 

231

 

 

 

965

 

 

 

806

 

Corporate(2)

 

 

(179

)

 

 

(169

)

 

 

(784

)

 

 

(704

)

 

 

 

 

 

 

 

 

 

Total Operating Profit

 

$

1,064

 

 

$

1,072

 

 

$

4,268

 

 

$

3,984

 

Notes: Tables may not sum due to rounding.

 

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

 

(2) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.

 

Corporate Operating profit (loss) for the three months ended December 31, 2024 included charges resulting from the 2022 Global Productivity Initiative of $7.

 

Corporate Operating profit (loss) for the three months ended December 31, 2023 included charges resulting from the 2022 Global Productivity Initiative of $2.

 

Corporate Operating profit (loss) for the twelve months ended December 31, 2024 included charges resulting from the 2022 Global Productivity Initiative of $85.

��

Corporate Operating profit (loss) for the twelve months ended December 31, 2023 included charges resulting from the 2022 Global Productivity Initiative of $27 and product recall costs of $25.

 

Table 6

Colgate-Palmolive Company

 

Geographic Sales Analysis Percentage Changes

 

For the Three Months Ended December 31, 2024 vs. 2023

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COMPONENTS OF SALES CHANGE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pricing

 

 

 

 

 

 

 

 

 

 

Coupons

 

 

 

 

Sales

 

 

 

 

 

Consumer &

 

 

 

 

Change

 

Organic

 

 

 

Trade

 

Foreign

Region

 

As Reported

 

Sales Change

 

Volume

 

Incentives

 

Exchange

 

 

 

 

 

 

 

 

 

 

 

Total Company

 

(0.1

)%

 

4.3

%

 

2.5

%

 

1.8

%

 

(4.4

)%

 

 

 

 

 

 

 

 

 

 

 

North America(1)

 

(1.0

)%

 

(0.7

)%

 

1.9

%

 

(2.7

)%

 

(0.3

)%

 

 

 

 

 

 

 

 

 

 

 

Latin America

 

(7.2

)%

 

9.2

%

 

0.9

%

 

8.3

%

 

(16.4

)%

 

 

 

 

 

 

 

 

 

 

 

Europe(1)

 

4.9

%

 

4.5

%

 

1.7

%

 

2.7

%

 

0.4

%

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

3.7

%

 

3.8

%

 

5.8

%

 

(2.0

)%

 

%

 

 

 

 

 

 

 

 

 

 

 

Africa/Eurasia

 

2.8

%

 

9.4

%

 

11.5

%

 

(2.1

)%

 

(6.6

)%

 

 

 

 

 

 

 

 

 

 

 

Total CP Products

 

(0.8

)%

 

4.7

%

 

2.9

%

 

1.8

%

 

(5.5

)%

 

 

 

 

 

 

 

 

 

 

 

Hill’s

 

2.3

%

 

2.9

%

 

0.8

%

 

2.0

%

 

(0.5

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Emerging Markets(2)

 

(2.2

)%

 

7.5

%

 

3.7

%

 

3.8

%

 

(9.7

)%

 

 

 

 

 

 

 

 

 

 

 

Developed Markets

 

1.6

%

 

1.7

%

 

1.5

%

 

0.3

%

 

(0.2

)%

Notes: Table may not sum due to rounding.

 

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

 

(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

 

Table 7

Colgate-Palmolive Company

 

Geographic Sales Analysis Percentage Changes

 

For the Twelve Months Ended December 31, 2024 vs. 2023

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COMPONENTS OF SALES CHANGE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pricing

 

 

 

 

 

 

 

 

 

 

Coupons

 

 

 

 

Sales

 

 

 

 

 

Consumer &

 

 

 

 

Change

 

Organic

 

 

 

Trade

 

Foreign

Region

 

As Reported

 

Sales Change

 

Volume

 

Incentives

 

Exchange

 

 

 

 

 

 

 

 

 

 

 

Total Company

 

3.3

%

 

7.4

%

 

3.1

%

 

4.4

%

 

(4.1

)%

 

 

 

 

 

 

 

 

 

 

 

North America(1)

 

0.5

%

 

0.7

%

 

2.6

%

 

(1.9

)%

 

(0.1

)%

 

 

 

 

 

 

 

 

 

 

 

Latin America

 

3.1

%

 

16.8

%

 

3.9

%

 

12.9

%

 

(13.7

)%

 

 

 

 

 

 

 

 

 

 

 

Europe(1)

 

7.7

%

 

6.7

%

 

4.1

%

 

2.5

%

 

1.1

%

 

 

 

 

 

 

 

 

 

 

 

Asia Pacific

 

2.7

%

 

4.0

%

 

3.1

%

 

1.0

%

 

(1.3

)%

 

 

 

 

 

 

 

 

 

 

 

Africa/Eurasia

 

1.2

%

 

13.3

%

 

7.6

%

 

5.7

%

 

(12.1

)%

 

 

 

 

 

 

 

 

 

 

 

Total CP Products

 

3.0

%

 

8.1

%

 

3.7

%

 

4.4

%

 

(5.2

)%

 

 

 

 

 

 

 

 

 

 

 

Hill’s

 

4.5

%

 

4.9

%

 

0.8

%

 

4.1

%

 

(0.4

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Emerging Markets(2)

 

3.0

%

 

12.2

%

 

4.0

%

 

8.2

%

 

(9.2

)%

 

 

 

 

 

 

 

 

 

 

 

Developed Markets

 

3.5

%

 

3.6

%

 

2.3

%

 

1.3

%

 

%

 
Note: Table may not sum due to rounding.
 

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

 

(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

 

Table 8

Colgate-Palmolive Company

 

 

 

 

 

 

 

Non-GAAP Reconciliations

 

 

 

 

 

 

 

For the Three Months Ended December 31, 2024 and 2023

 

 

 

 

 

 

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

 

 

 

 

 

 

Gross Profit

 

 

2024

 

 

 

2023

 

 

 

Gross profit, GAAP

 

$

2,982

 

 

$

2,950

 

 

 

2022 Global Productivity Initiative

 

 

1

 

 

 

 

 

 

Gross profit, non-GAAP

 

$

2,983

 

 

$

2,950

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

2024

 

 

 

2023

 

 

 

Selling, general and administrative expenses, GAAP

 

$

1,895

 

 

$

1,803

 

 

 

2022 Global Productivity Initiative

 

 

(1

)

 

 

 

 

 

Selling, general and administrative expenses, non-GAAP

 

$

1,894

 

 

$

1,803

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other (Income) Expense, Net

 

 

2024

 

 

 

2023

 

 

 

Other (income) expense, net, GAAP

 

$

23

 

 

$

75

 

 

 

2022 Global Productivity Initiative

 

 

(5

)

 

 

(2

)

 

 

Other (income) expense, net, non-GAAP

 

$

18

 

 

$

73

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Profit

 

 

2024

 

 

 

2023

 

 

% Change

Operating profit, GAAP

 

$

1,064

 

 

$

1,072

 

 

(1

)%

2022 Global Productivity Initiative

 

 

7

 

 

 

2

 

 

 

Operating profit, non-GAAP

 

$

1,071

 

 

$

1,074

 

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis Point

Operating Profit Margin

 

 

2024

 

 

 

2023

 

 

Change

Operating profit margin, GAAP

 

 

21.5

%

 

 

21.7

%

 

(20

)

2022 Global Productivity Initiative

 

 

0.2

%

 

 

%

 

 

Operating profit margin, non-GAAP

 

 

21.7

%

 

 

21.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-Service Related Post Retirement Cost

 

 

2024

 

 

 

2023

 

 

 

Non-service related post retirement cost, GAAP

 

$

20

 

 

$

22

 

 

 

2022 Global Productivity Initiative

 

 

 

 

 

(1

)

 

 

Non-service post retirement cost, non-GAAP

 

$

20

 

 

$

21

 

 

 

 

Table 8

Continued

Colgate-Palmolive Company

 

 

 

 

 

 

 

Non-GAAP Reconciliations

 

 

 

 

 

 

 

For the Three Months Ended December 31, 2024 vs. 2023

 

 

 

 

 

 

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2024

 

Income Before

Income Taxes

Provision For

Income Taxes(1)

Net Income

Including

Noncontrolling

Interests

Net Income

Atributable To

Colgate-

Palmolive

Company

Effective Income

Tax Rate(2)

Diluted

Earnings

Per Share

As Reported GAAP

$

994

$

215

$

779

$

739

21.6

%

$

0.90

2022 Global Productivity Initiative

 

7

 

1

 

6

 

6

%

 

0.01

Non-GAAP

$

1,001

$

216

$

785

$

745

21.6

%

$

0.91

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2023

 

Income Before

Income Taxes

Provision For

Income Taxes(1)

Net Income

Including

Noncontrolling

Interests

Net Income

Attributable To

Colgate-

Palmolive


Company

Effective Income

Tax Rate(2)

Diluted

Earnings

Per Share

As Reported GAAP

$

988

$

228

$

760

$

718

23.1

%

$

0.87

2022 Global Productivity Initiative

 

3

 

1

 

2

 

2

%

 

Non-GAAP

$

991

$

229

$

762

$

720

23.1

%

$

0.87

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.
 

Notes:

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

 

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

 

Table 9

Colgate-Palmolive Company

 

 

 

 

 

 

 

Non-GAAP Reconciliations

 

 

 

 

 

 

 

For the Twelve Months Ended December 31, 2024 vs. 2023

 

 

 

 

 

 

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

 

 

 

 

 

 

Gross Profit

 

 

2024

 

 

 

2023

 

 

 

Gross profit, GAAP

 

$

12,161

 

 

$

11,326

 

 

 

2022 Global Productivity Initiative

 

 

20

 

 

 

1

 

 

 

Gross profit, non-GAAP

 

$

12,181

 

 

$

11,327

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis Point

Gross Profit Margin

 

 

2024

 

 

 

2023

 

 

Change

Gross profit margin, GAAP

 

 

60.5

%

 

 

58.2

%

 

230

 

2022 Global Productivity Initiative

 

 

0.1

%

 

 

%

 

 

Gross profit margin, non-GAAP

 

 

60.6

%

 

 

58.2

%

 

240

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

2024

 

 

 

2023

 

 

 

Selling, general and administrative expenses, GAAP

 

$

7,729

 

 

$

7,151

 

 

 

2022 Global Productivity Initiative

 

 

(6

)

 

 

(2

)

 

 

Selling, general and administrative expenses, non-GAAP

 

$

7,723

 

 

$

7,149

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis Point

Selling, General and Administrative Expenses as a Percentage of Net Sales

 

 

2024

 

 

 

2023

 

 

Change

Selling, general and administrative expenses as a percentage of Net sales, GAAP

 

 

38.5

%

 

 

36.8

%

 

170

 

2022 Global Productive Initiative

 

 

(0.1

)%

 

 

(0.1

)%

 

 

Selling, general and administrative expenses as a percentage of Net sales, non-GAAP

 

 

38.4

%

 

 

36.7

%

 

170

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other (Income) Expense, Net

 

 

2024

 

 

 

2023

 

 

 

Other (income) expense, net, GAAP

 

$

164

 

 

$

191

 

 

 

2022 Global Productivity Initiative

 

 

(59

)

 

 

(24

)

 

 

Product recall costs

 

 

 

 

 

(25

)

 

 

Other (income) expense, net, non-GAAP

 

$

105

 

 

$

142

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Profit

 

 

2024

 

 

 

2023

 

 

% Change

Operating profit, GAAP

 

$

4,268

 

 

$

3,984

 

 

7

%

2022 Global Productivity Initiative

 

 

85

 

 

 

27

 

 

 

Product recall costs

 

 

 

 

 

25

 

 

 

Operating profit, non-GAAP

 

$

4,353

 

 

$

4,036

 

 

8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

Basis Point

Operating Profit Margin

 

 

2024

 

 

 

2023

 

 

Change

Operating profit margin, GAAP

 

 

21.2

%

 

 

20.5

%

 

70

 

2022 Global Productivity Initiative

 

 

0.5

%

 

 

0.1

%

 

 

Product recall costs

 

 

%

 

 

0.1

%

 

 

Operating profit margin, non-GAAP

 

 

21.7

%

 

 

20.7

%

 

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-Service Related Post Retirement Cost

 

 

2024

 

 

 

2023

 

 

 

Non-service related post retirement cost, GAAP

 

$

87

 

 

$

360

 

 

 

ERISA litigation matter

 

 

 

 

 

(267

)

 

 

2022 Global Productivity Initiative

 

 

 

 

 

(5

)

 

 

Non-service post retirement cost, non-GAAP

 

$

87

 

 

$

88

 

 

 

 

 

 

 

 

 

 

Table 9

Continued

Colgate-Palmolive Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Reconciliations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Twelve Months Ended December 31, 2024 vs. 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Dollars in Millions Except Per Share Amounts) (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2024

 

Income

Before

Income Taxes

 

Provision

For Income

Taxes(1)

 

Net Income

Including

Noncontrolling

Interests

 

Less: Income

Attributable to

Noncontrolling

Interests

 

Net Income

Attributable

To

Colgate-

Palmolive

Company

 

Effective

Income

Tax Rate(2)

 

Diluted

Earnings

Per Share

As Reported GAAP

$

3,956

 

$

907

 

 

$

3,049

 

$

160

 

$

2,889

 

22.9

%

 

$

3.51

2022 Global Productivity Initiative

 

85

 

 

12

 

 

 

73

 

 

 

 

73

 

(0.2

)%

 

 

0.09

Non-GAAP

$

4,041

 

$

919

 

 

$

3,122

 

$

160

 

$

2,962

 

22.7

%

 

$

3.60

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2023

 

Income

Before

Income Taxes

 

Provision

For Income

Taxes(1)

 

Net Income

Including

Noncontrolling

Interests

 

Less: Income

Attributable to

Noncontrolling

Interests

 

Net Income

Attributable

To

Colgate-

Palmolive

Company

 

Effective

Income

Tax Rate(2)

 

Diluted

Earnings

Per Share

As Reported GAAP

$

3,392

 

$

937

 

 

$

2,455

 

$

155

 

$

2,300

 

27.6

%

 

$

2.77

ERISA litigation matter

 

267

 

 

55

 

 

 

212

 

 

 

 

212

 

(0.5

)%

 

 

0.26

Foreign tax matter

 

 

 

(126

)

 

 

126

 

 

 

 

126

 

(3.4

)%

 

 

0.15

2022 Global Productivity Initiative

 

32

 

 

6

 

 

 

26

 

 

1

 

 

25

 

(0.1

)%

 

 

0.03

Product recall costs

 

25

 

 

6

 

 

 

19

 

 

 

 

19

 

%

 

 

0.02

Non-GAAP

$

3,716

 

$

878

 

 

$

2,838

 

$

156

 

$

2,682

 

23.6

%

 

$

3.23

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

 

Notes:

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

 

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.